Professor Chris Halsey
- Head of School/ Professor of Paediatric Haemato-Oncology, Head of School, Cancer Sciences (Clinical Research Garscube)
telephone:
01413304811
email:
Chris.Halsey@glasgow.ac.uk
Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, Garscube Estate, Bearsden, G61 1QH
Research interests
Please see my group site: Childhood Leukaemia Research Group (Halsey Lab)
Research groups
- Cancer Hallmarks to Novel Therapies
- Cancer Evolution in Time & Space
- Immunology & Cancer
- Comprehensive Cancer Models
- Leukaemia
Publications
2024
Apps, J. et al. (2024) A review calling for research directed at early detection of childhood cancers: the clinical, scientific, and economic arguments for population screening and surveillance. EJC Paediatric Oncology, (Accepted for Publication)
Anastasopoulou, S. et al. (2024) Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study. British Journal of Haematology, (doi: 10.1111/bjh.19610) (PMID:38924051) (Early Online Publication)
2022
Cousins, A. et al. (2022) Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways. Leukemia, 36(12), pp. 2903-2907. (doi: 10.1038/s41375-022-01722-x) (PMID:36289348) (PMCID:PMC9712090)
Thastrup, M., Duguid, A., Mirian, C., Schmiegelow, K. and Halsey, C. (2022) Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions. Leukemia, 36(12), pp. 2751-2768. (doi: 10.1038/s41375-022-01714-x) (PMID:36266325)
Pal, D. et al. (2022) hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia. Cell Reports Medicine, 3(8), 100717. (doi: 10.1016/j.xcrm.2022.100717) (PMID:35977468) (PMCID:PMC9418860)
2021
Malouf, C., Antunes, E. T.B., O'Dwyer, M., Jakobczyk, H., Sahm, F., Landua, S.-L., Anderson, R. A., Soufi, A., Halsey, C. and Ottersbach, K. (2021) MiR-130b and miR-128a are essential lineage-specific co-drivers of t(4;11) MLL-AF4 acute leukemia. Blood, 138(21), pp. 2066-2092. (doi: 10.1182/blood.2020006610) (PMID:34111240)
Rice, S. et al. (2021) A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program. Nature Communications, 12, 6905. (doi: 10.1038/s41467-021-27270-z) (PMID:34824279) (PMCID:PMC8616957)
Zanetti, C. et al. (2021) The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13. Blood, 138(19), pp. 1870-1884. (doi: 10.1182/blood.2021011557) (PMID:34424946)
Halsey, C. and Escherich, G. (2021) A “Goldilocks” approach to CNS leukaemia is needed. Blood, 138(4), pp. 288-289. (doi: 10.1182/blood.2021011461) (PMID:34323942)
Andrés-Jensen, L. et al. (2021) Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. Lancet Haematology, 8(7), e513-e523. (doi: 10.1016/S2352-3026(21)00136-8) (PMID:34171282)
Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi: 10.17605/OSF.IO/KWHQF).
Shi, Y. et al. (2021) Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia. Haematologica, 106(4), pp. 1056-1066. (doi: 10.3324/haematol.2019.241026) (PMID:32139432) (PMCID:PMC8018112)
Lenk, L. et al. (2021) CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia. Communications Biology, 4, 73. (doi: 10.1038/s42003-020-01591-z) (PMID:33452446) (PMCID:PMC7810877)
2020
Savino, A. M. et al. (2020) Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment depends on Stearoyl CoA desaturase. Nature Cancer, 1(10), pp. 998-1009. (doi: 10.1038/s43018-020-00115-2) (PMID:33479702) (PMCID:PMC7116605)
Abdelrasoul, H. et al. (2020) Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature Communications, 11, 3194. (doi: 10.1038/s41467-020-16927-w) (PMID:32581241) (PMCID:PMC7314847)
Walker, D. A., Meijer, L., Coyle, B. and Halsey, C. (2020) Leptomeningeal malignancy of childhood: sharing learning between childhood leukaemia and brain tumour trials. Lancet Child and Adolescent Health, 4(3), pp. 242-250. (doi: 10.1016/S2352-4642(19)30333-5) (PMID:31958415)
Forster, V. J., Bell, G. and Halsey, C. (2020) Should nitrous oxide ever be used in oncology patients receiving methotrexate therapy? Pediatric Anesthesia, 30(1), pp. 9-16. (doi: 10.1111/pan.13760) (PMID:31667903)
2019
Yousafzai, Y. M. et al. (2019) Use of quantitative polymerase chain reaction (qPCR) for the diagnosis and monitoring of CNS leukaemia. Leukemia Research, 87, 10623. (doi: 10.1016/j.leukres.2019.106232) (PMID:31706196)
Matheson, E. C. et al. (2019) Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM. Haematologica, 104(9), pp. 1804-1811. (doi: 10.3324/haematol.2017.185975) (PMID:30655370) (PMCID:PMC6717586)
Baquero, P. et al. (2019) Targeting quiescent leukemic stem cells using second generation autophagy inhibitors. Leukemia, 33(4), pp. 981-994. (doi: 10.1038/s41375-018-0252-4) (PMID:30185934) (PMCID:PMC6292500)
2018
Alsadeq, A. et al. (2018) IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia. Blood, 132(15), pp. 1614-1617. (doi: 10.1182/blood-2018-04-844209) (PMID:30154115) (PMCID:PMC6238156)
Halsey, C. (2018) Challenging "privileged" stereotypes - leukemic blasts and the central nervous system. Leukemia Research, 73, pp. 76-77. (doi: 10.1016/j.leukres.2018.08.013) (PMID:30243134)
Wilson, R., Osborne, C. and Halsey, C. (2018) The use of Ommaya reservoirs to deliver central nervous system directed chemotherapy in childhood acute lymphoblastic leukaemia. Pediatric Drugs, 20(4), pp. 293-301. (doi: 10.1007/s40272-018-0298-9) (PMID:29850985)
Forster, V., Escherich, G. and Halsey, C. (2018) Comment on: Successful use of nitrous oxide during lumbar punctures: a call for nitrous oxide in pediatric oncology clinics. Pediatric Blood and Cancer, 65(5), e26930. (doi: 10.1002/pbc.26930) (PMID:29286566)
De Santo, C. et al. (2018) The arginine metabolome in Acute Lymphoblastic Leukemia can be targeted by the PEG-recombinant Arginase I BCT-100. International Journal of Cancer, 142(7), pp. 1490-1502. (doi: 10.1002/ijc.31170) (PMID:29168171) (PMCID:PMC5849425)
Sinclair, P. B. et al. (2018) Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Haematologica, 103(4), pp. 634-644. (doi: 10.3324/haematol.2017.172304) (PMID:29449437) (PMCID:PMC5865429)
Bartram, J., Goulden, N., Wright, G., Adams, S., Brooks, T., Edwards, D., Inglott, S., Yousafzai, Y., Hubank, M. and Halsey, C. (2018) High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments. Haematologica, 103, e113. (doi: 10.3324/haematol.2017.174987) (PMID:29217777)
2017
Cousins, A. et al. (2017) Upregulated cholesterol biosynthesis is a biomarker for isolated central nervous system relapse in acute lymphoblastic leukaemia. Blood, 130(Sup 1), 3992.
Forster, V. J., van Delft, F. W., Baird, S. F., Mair, S., Skinner, R. and Halsey, C. (2017) Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect. Cancer Chemotherapy and Pharmacology, 79(4), pp. 841-842. (doi: 10.1007/s00280-017-3270-4) (PMID:28289862)
Cousins, A. F., Olivares, O., Michie, A. M. , Gottlieb, E. and Halsey, C. (2017) Association of CNS Involvement in Childhood Acute Lymphoblastic Leukaemia with Cholesterol Biosynthesis Upregulation. Spring Meeting for Clinician Scientists in Training 2017, London, UK, 23 Feb 2017. S35. (doi: 10.1016/S0140-6736(17)30431-2)
Oruganti, S.R., Torres, D.J., Krebsbach, S., Asperti-Boursin, F., Winters, J., Matlawska-Wasowska, K., Winter, S.S., Halsey, C. and Cannon, J.L. (2017) CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS. Leukemia, 31(1), pp. 255-258. (doi: 10.1038/leu.2016.272) (PMID:27698445)
2016
Forster, V. J., van Delft, F. W., Baird, S. F., Mair, S., Skinner, R. and Halsey, C. (2016) Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients. Cancer Chemotherapy and Pharmacology, 78(5), pp. 1093-1096. (doi: 10.1007/s00280-016-3153-0) (PMID:27659182) (PMCID:PMC5083755)
Schmiegelow, K. et al. (2016) Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncology, 17(6), e231-e239. (doi: 10.1016/S1470-2045(16)30035-3)
Williams, M. T.S. et al. (2016) The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukaemia blasts. Blood, 127, 16. (doi: 10.1182/blood-2015-08-665034) (PMID:26869395)
2015
Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E. and Halsey, C. (2015) Research into cancer metabolomics: towards a clinical metamorphosis. Seminars in Cell and Developmental Biology, 43, pp. 52-64. (doi: 10.1016/j.semcdb.2015.09.008) (PMID:26365277)
2014
Irving, J. et al. (2014) Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood, 124(23), pp. 3420-3430. (doi: 10.1182/blood-2014-04-531871) (PMID:25253770) (PMCID:PMC4246039)
Winter, S. and Halsey, C. (2014) Should children presenting with iron deficiency anaemia be screened for coeliac disease? Archives of Disease in Childhood, 99(2), pp. 180-182. (doi: 10.1136/archdischild-2013-305591)
El-Fakhri, N., McDevitt, H., Shaikh, M.G., Halsey, C. and Ahmed, S.F. (2014) Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function. Hormone Research in Paediatrics, 81(6), pp. 363-378. (doi: 10.1159/000357731)
Halsey, C. (2014) Haematological investigations in paediatrics. In: Goal, K.M. and Carachi, R. (eds.) Hutchison's Atlas of Paediatric Physical Diagnosis. Jaypee Brothers Medical Publishers: New Delhi. ISBN 9789351521525
Halsey, C. (2014) Towards personalised medicine in childhood acute lymphoblastic leukaemia. In: Thomas, A.E. and Halsey, C. (eds.) Controversies in Pediatric and Adolescent Hematology. Kerger, pp. 98-115. ISBN 9783318024234 (doi: 10.1159/000350349)
Thomas, A.E. and Halsey, C. (2014) Controversies in Pediatric and Adolescent Hematology. Series: Pediatric and Adolescent Medicine. Karger. ISBN 9783318024227
Williams, M. T.S. et al. (2014) Interleukin-15 enhances cellular proliferation and up-regulates CNS homing molecules in pre-B acute lymphoblastic leukemia. Blood, 123(20), pp. 3116-3127. (doi: 10.1182/blood-2013-05-499970) (PMID:24700781)
2013
Yasar, M. Y. et al. (2013) 3866 An Analysis of Mechanisms of Central Nervous System Infiltration in Acute Lymphoblastic Leukaemia Using Primary Cells Xenografted Into Immunodeficient Mice. 55th ASH Annual Meeting and Exposition, New Orleans, LA, USA, 7-10 Dec 2013.
Roberts, I. et al. (2013) GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood, 122(24), pp. 3908-3917. (doi: 10.1182/blood-2013-07-515148)
2012
Halsey, C. , Docherty, M., McNeill, M., Gilchrist, D., Le Brocq, M., Gibson, B. and Graham, G. (2012) The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells. Journal of Hematology and Oncology, 5, p. 45. (doi: 10.1186/1756-8722-5-45)
2011
Williams, M.T., Graham, G. , Gibson, B. and Halsey, C. (2011) Homing to the central nervous system is associated with differential expression of selectins, integrins and chemokine receptors in pre-B acute lymphoblastic leukaemia cell lines. In: 51st Annual Scientific Meeting of the British Society for Haematology, Brighton, UK, 4-6 April 2011, pp. 1-88. (doi: 10.1111/j.1365-2141.2011.08609.x)
Williams, M.T., Graham, G. , Gibson, B. and Halsey, C. (2011) An investigation into the role of interleukin-15 on the growth and survival of pre-B acute lymphoblastic leukaemia cell lines. In: 51st Annual Scientific Meeting of the British Society for Haematology, Brighton, UK, 4-6 April 2011, pp. 1-88. (doi: 10.1111/j.1365-2141.2011.08609.x)
Halsey, C. , Buck, G., Richards, S., Vargha-Khadem, F., Hill, F. and Gibson, B. (2011) The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. Journal of Hematology and Oncology, 4(42), (doi: 10.1186/1756-8722-4-42)
2010
Halsey, C. , Lumley, H. and Luckit, J. (2010) Necrotising external otitis caused by Aspergillus wentii: a case report. Mycoses, 54(4), E211-E213. (doi: 10.1111/J.1439-0507.2009.01815.x)
Halsey, C. , Tunstall, O., Gibson, B., Roberts, I. and Graham, G. (2010) Role of GATA-1s in early hematopoiesis and differences between alternative splicing in human and murine GATA-1. Blood, 115(16), pp. 3415-3416. (doi: 10.1182/blood-2010-02-267930)
2009
Halsey, C. and Chalmers, E.A. (2009) Haematalogical investigations in children. In: Goel, K. and Gupta, D. (eds.) Hutchison's Paediatrics. Jaypee Brothers, Medical Publishers (P) Ltd.. ISBN 9788184485868
2008
McKimmie, C. S. et al. (2008) Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. Journal of Immunology, 181(5), pp. 3353-3363. (doi: 10.4049/jimmunol.181.11.8170-a) (PMID:19039854)
Halsey, C.,. and Chalmers, E.A. (2008) Haematological investigations in paediatrics. In: Goel, K.M. and Gupta, D.K. (eds.) Hutchison's Paediatrics. Jaypee Brothers Medical Publishers: New Delhi. ISBN 9788184485868
Halsey, C. and Roberts, I. (2008) Neonatal Haematology. In: Forfar, J.O. and McIntosh, N. (eds.) Forfar and Arneil's Textbook of Pediatrics. Churchill Livingstone: Edinburgh. ISBN 9780443103971
2007
Halsey, C. , Fisher, C., Strathdee, G., Gibson, B., Holyoake, T., Vyas, P. and Graham, G. (2007) GATA1 mutational analysis in chronic myeloid leukaemia. British Journal of Haematology, 137(4), pp. 375-376. (doi: 10.1111/j.1365-2141.2007.06563.x) (PMID:17408401)
2006
Gibson, B. E.S. and Halsey, C. (2006) Nonimmune neonatal anemias. In: Arceci, R., Hann, I. M. and Smith, O. P. (eds.) Pediatric Hematology. Blackwell Publishing: Malden, pp. 130-150. ISBN 9781405134002 (doi: 10.1002/9780470987001.ch7)
2004
Jiskoot, P.M.C., Halsey, C. , Rivers, R., Bain, B.J. and Wilkins, B.S. (2004) Unusual splenic sinusoidal iron overload in sickle cell/haemoglobin D-Punjab disease. Journal of Clinical Pathology, 57(5), pp. 539-540. (doi: 10.1136/jcp.2002.004481) (PMID:15113864) (PMCID:PMC1770290)
2003
Ronghe, M. D., Halsey, C. and Goulden, N. J. (2003) Anticoagulation therapy in children. Pediatric Drugs, 5(12), pp. 803-820. (doi: 10.2165/00148581-200305120-00004) (PMID:14658922)
Amrolia, P. J., Almeida, A., Halsey, C. , Roberts, I. A. G. and Davies, S. C. (2003) Therapeutic challenges in childhood sickle cell disease part 1: current and future treatment options. British Journal of Haematology, 120(5), pp. 725-736. (doi: 10.1046/j.1365-2141.2003.04143.x) (PMID:12614202)
Halsey, C. and Roberts, I. A.G. (2003) The role of hydroxyurea in sickle cell disease. British Journal of Haematology, 120(2), pp. 177-186. (doi: 10.1046/j.1365-2141.2003.03849.x) (PMID:12542474)
Halsey, C. and Roberts, I. (2003) haemopoietic stem cell transplantation for thalassaemia and sickle cell disease. In: Okpala, I.E. (ed.) Comprehensive Care of Sickle Cell Disease. UNSPECIFIED.
Halsey, C. and Roberts, I. (2003) Neonatal Haematology. In: Forfar, J.O., Arneil, G.C., McIntosh, N., Helms, P. and Smyth, R.L. (eds.) Forfar and Arneil's Textbook of Pediatrics. Churchill Livingstone: Edinburgh. ISBN 9780443071980
Articles
Apps, J. et al. (2024) A review calling for research directed at early detection of childhood cancers: the clinical, scientific, and economic arguments for population screening and surveillance. EJC Paediatric Oncology, (Accepted for Publication)
Anastasopoulou, S. et al. (2024) Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study. British Journal of Haematology, (doi: 10.1111/bjh.19610) (PMID:38924051) (Early Online Publication)
Cousins, A. et al. (2022) Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways. Leukemia, 36(12), pp. 2903-2907. (doi: 10.1038/s41375-022-01722-x) (PMID:36289348) (PMCID:PMC9712090)
Thastrup, M., Duguid, A., Mirian, C., Schmiegelow, K. and Halsey, C. (2022) Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions. Leukemia, 36(12), pp. 2751-2768. (doi: 10.1038/s41375-022-01714-x) (PMID:36266325)
Pal, D. et al. (2022) hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia. Cell Reports Medicine, 3(8), 100717. (doi: 10.1016/j.xcrm.2022.100717) (PMID:35977468) (PMCID:PMC9418860)
Malouf, C., Antunes, E. T.B., O'Dwyer, M., Jakobczyk, H., Sahm, F., Landua, S.-L., Anderson, R. A., Soufi, A., Halsey, C. and Ottersbach, K. (2021) MiR-130b and miR-128a are essential lineage-specific co-drivers of t(4;11) MLL-AF4 acute leukemia. Blood, 138(21), pp. 2066-2092. (doi: 10.1182/blood.2020006610) (PMID:34111240)
Rice, S. et al. (2021) A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program. Nature Communications, 12, 6905. (doi: 10.1038/s41467-021-27270-z) (PMID:34824279) (PMCID:PMC8616957)
Zanetti, C. et al. (2021) The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13. Blood, 138(19), pp. 1870-1884. (doi: 10.1182/blood.2021011557) (PMID:34424946)
Halsey, C. and Escherich, G. (2021) A “Goldilocks” approach to CNS leukaemia is needed. Blood, 138(4), pp. 288-289. (doi: 10.1182/blood.2021011461) (PMID:34323942)
Andrés-Jensen, L. et al. (2021) Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. Lancet Haematology, 8(7), e513-e523. (doi: 10.1016/S2352-3026(21)00136-8) (PMID:34171282)
Shi, Y. et al. (2021) Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia. Haematologica, 106(4), pp. 1056-1066. (doi: 10.3324/haematol.2019.241026) (PMID:32139432) (PMCID:PMC8018112)
Lenk, L. et al. (2021) CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia. Communications Biology, 4, 73. (doi: 10.1038/s42003-020-01591-z) (PMID:33452446) (PMCID:PMC7810877)
Savino, A. M. et al. (2020) Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment depends on Stearoyl CoA desaturase. Nature Cancer, 1(10), pp. 998-1009. (doi: 10.1038/s43018-020-00115-2) (PMID:33479702) (PMCID:PMC7116605)
Abdelrasoul, H. et al. (2020) Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature Communications, 11, 3194. (doi: 10.1038/s41467-020-16927-w) (PMID:32581241) (PMCID:PMC7314847)
Walker, D. A., Meijer, L., Coyle, B. and Halsey, C. (2020) Leptomeningeal malignancy of childhood: sharing learning between childhood leukaemia and brain tumour trials. Lancet Child and Adolescent Health, 4(3), pp. 242-250. (doi: 10.1016/S2352-4642(19)30333-5) (PMID:31958415)
Forster, V. J., Bell, G. and Halsey, C. (2020) Should nitrous oxide ever be used in oncology patients receiving methotrexate therapy? Pediatric Anesthesia, 30(1), pp. 9-16. (doi: 10.1111/pan.13760) (PMID:31667903)
Yousafzai, Y. M. et al. (2019) Use of quantitative polymerase chain reaction (qPCR) for the diagnosis and monitoring of CNS leukaemia. Leukemia Research, 87, 10623. (doi: 10.1016/j.leukres.2019.106232) (PMID:31706196)
Matheson, E. C. et al. (2019) Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM. Haematologica, 104(9), pp. 1804-1811. (doi: 10.3324/haematol.2017.185975) (PMID:30655370) (PMCID:PMC6717586)
Baquero, P. et al. (2019) Targeting quiescent leukemic stem cells using second generation autophagy inhibitors. Leukemia, 33(4), pp. 981-994. (doi: 10.1038/s41375-018-0252-4) (PMID:30185934) (PMCID:PMC6292500)
Alsadeq, A. et al. (2018) IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia. Blood, 132(15), pp. 1614-1617. (doi: 10.1182/blood-2018-04-844209) (PMID:30154115) (PMCID:PMC6238156)
Halsey, C. (2018) Challenging "privileged" stereotypes - leukemic blasts and the central nervous system. Leukemia Research, 73, pp. 76-77. (doi: 10.1016/j.leukres.2018.08.013) (PMID:30243134)
Wilson, R., Osborne, C. and Halsey, C. (2018) The use of Ommaya reservoirs to deliver central nervous system directed chemotherapy in childhood acute lymphoblastic leukaemia. Pediatric Drugs, 20(4), pp. 293-301. (doi: 10.1007/s40272-018-0298-9) (PMID:29850985)
Forster, V., Escherich, G. and Halsey, C. (2018) Comment on: Successful use of nitrous oxide during lumbar punctures: a call for nitrous oxide in pediatric oncology clinics. Pediatric Blood and Cancer, 65(5), e26930. (doi: 10.1002/pbc.26930) (PMID:29286566)
De Santo, C. et al. (2018) The arginine metabolome in Acute Lymphoblastic Leukemia can be targeted by the PEG-recombinant Arginase I BCT-100. International Journal of Cancer, 142(7), pp. 1490-1502. (doi: 10.1002/ijc.31170) (PMID:29168171) (PMCID:PMC5849425)
Sinclair, P. B. et al. (2018) Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21. Haematologica, 103(4), pp. 634-644. (doi: 10.3324/haematol.2017.172304) (PMID:29449437) (PMCID:PMC5865429)
Bartram, J., Goulden, N., Wright, G., Adams, S., Brooks, T., Edwards, D., Inglott, S., Yousafzai, Y., Hubank, M. and Halsey, C. (2018) High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments. Haematologica, 103, e113. (doi: 10.3324/haematol.2017.174987) (PMID:29217777)
Cousins, A. et al. (2017) Upregulated cholesterol biosynthesis is a biomarker for isolated central nervous system relapse in acute lymphoblastic leukaemia. Blood, 130(Sup 1), 3992.
Forster, V. J., van Delft, F. W., Baird, S. F., Mair, S., Skinner, R. and Halsey, C. (2017) Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect. Cancer Chemotherapy and Pharmacology, 79(4), pp. 841-842. (doi: 10.1007/s00280-017-3270-4) (PMID:28289862)
Oruganti, S.R., Torres, D.J., Krebsbach, S., Asperti-Boursin, F., Winters, J., Matlawska-Wasowska, K., Winter, S.S., Halsey, C. and Cannon, J.L. (2017) CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS. Leukemia, 31(1), pp. 255-258. (doi: 10.1038/leu.2016.272) (PMID:27698445)
Forster, V. J., van Delft, F. W., Baird, S. F., Mair, S., Skinner, R. and Halsey, C. (2016) Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients. Cancer Chemotherapy and Pharmacology, 78(5), pp. 1093-1096. (doi: 10.1007/s00280-016-3153-0) (PMID:27659182) (PMCID:PMC5083755)
Schmiegelow, K. et al. (2016) Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncology, 17(6), e231-e239. (doi: 10.1016/S1470-2045(16)30035-3)
Williams, M. T.S. et al. (2016) The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukaemia blasts. Blood, 127, 16. (doi: 10.1182/blood-2015-08-665034) (PMID:26869395)
Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E. and Halsey, C. (2015) Research into cancer metabolomics: towards a clinical metamorphosis. Seminars in Cell and Developmental Biology, 43, pp. 52-64. (doi: 10.1016/j.semcdb.2015.09.008) (PMID:26365277)
Irving, J. et al. (2014) Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood, 124(23), pp. 3420-3430. (doi: 10.1182/blood-2014-04-531871) (PMID:25253770) (PMCID:PMC4246039)
Winter, S. and Halsey, C. (2014) Should children presenting with iron deficiency anaemia be screened for coeliac disease? Archives of Disease in Childhood, 99(2), pp. 180-182. (doi: 10.1136/archdischild-2013-305591)
El-Fakhri, N., McDevitt, H., Shaikh, M.G., Halsey, C. and Ahmed, S.F. (2014) Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function. Hormone Research in Paediatrics, 81(6), pp. 363-378. (doi: 10.1159/000357731)
Williams, M. T.S. et al. (2014) Interleukin-15 enhances cellular proliferation and up-regulates CNS homing molecules in pre-B acute lymphoblastic leukemia. Blood, 123(20), pp. 3116-3127. (doi: 10.1182/blood-2013-05-499970) (PMID:24700781)
Roberts, I. et al. (2013) GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood, 122(24), pp. 3908-3917. (doi: 10.1182/blood-2013-07-515148)
Halsey, C. , Docherty, M., McNeill, M., Gilchrist, D., Le Brocq, M., Gibson, B. and Graham, G. (2012) The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells. Journal of Hematology and Oncology, 5, p. 45. (doi: 10.1186/1756-8722-5-45)
Halsey, C. , Buck, G., Richards, S., Vargha-Khadem, F., Hill, F. and Gibson, B. (2011) The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. Journal of Hematology and Oncology, 4(42), (doi: 10.1186/1756-8722-4-42)
Halsey, C. , Lumley, H. and Luckit, J. (2010) Necrotising external otitis caused by Aspergillus wentii: a case report. Mycoses, 54(4), E211-E213. (doi: 10.1111/J.1439-0507.2009.01815.x)
Halsey, C. , Tunstall, O., Gibson, B., Roberts, I. and Graham, G. (2010) Role of GATA-1s in early hematopoiesis and differences between alternative splicing in human and murine GATA-1. Blood, 115(16), pp. 3415-3416. (doi: 10.1182/blood-2010-02-267930)
McKimmie, C. S. et al. (2008) Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. Journal of Immunology, 181(5), pp. 3353-3363. (doi: 10.4049/jimmunol.181.11.8170-a) (PMID:19039854)
Halsey, C. , Fisher, C., Strathdee, G., Gibson, B., Holyoake, T., Vyas, P. and Graham, G. (2007) GATA1 mutational analysis in chronic myeloid leukaemia. British Journal of Haematology, 137(4), pp. 375-376. (doi: 10.1111/j.1365-2141.2007.06563.x) (PMID:17408401)
Jiskoot, P.M.C., Halsey, C. , Rivers, R., Bain, B.J. and Wilkins, B.S. (2004) Unusual splenic sinusoidal iron overload in sickle cell/haemoglobin D-Punjab disease. Journal of Clinical Pathology, 57(5), pp. 539-540. (doi: 10.1136/jcp.2002.004481) (PMID:15113864) (PMCID:PMC1770290)
Ronghe, M. D., Halsey, C. and Goulden, N. J. (2003) Anticoagulation therapy in children. Pediatric Drugs, 5(12), pp. 803-820. (doi: 10.2165/00148581-200305120-00004) (PMID:14658922)
Amrolia, P. J., Almeida, A., Halsey, C. , Roberts, I. A. G. and Davies, S. C. (2003) Therapeutic challenges in childhood sickle cell disease part 1: current and future treatment options. British Journal of Haematology, 120(5), pp. 725-736. (doi: 10.1046/j.1365-2141.2003.04143.x) (PMID:12614202)
Halsey, C. and Roberts, I. A.G. (2003) The role of hydroxyurea in sickle cell disease. British Journal of Haematology, 120(2), pp. 177-186. (doi: 10.1046/j.1365-2141.2003.03849.x) (PMID:12542474)
Book Sections
Halsey, C. (2014) Haematological investigations in paediatrics. In: Goal, K.M. and Carachi, R. (eds.) Hutchison's Atlas of Paediatric Physical Diagnosis. Jaypee Brothers Medical Publishers: New Delhi. ISBN 9789351521525
Halsey, C. (2014) Towards personalised medicine in childhood acute lymphoblastic leukaemia. In: Thomas, A.E. and Halsey, C. (eds.) Controversies in Pediatric and Adolescent Hematology. Kerger, pp. 98-115. ISBN 9783318024234 (doi: 10.1159/000350349)
Halsey, C. and Chalmers, E.A. (2009) Haematalogical investigations in children. In: Goel, K. and Gupta, D. (eds.) Hutchison's Paediatrics. Jaypee Brothers, Medical Publishers (P) Ltd.. ISBN 9788184485868
Halsey, C.,. and Chalmers, E.A. (2008) Haematological investigations in paediatrics. In: Goel, K.M. and Gupta, D.K. (eds.) Hutchison's Paediatrics. Jaypee Brothers Medical Publishers: New Delhi. ISBN 9788184485868
Halsey, C. and Roberts, I. (2008) Neonatal Haematology. In: Forfar, J.O. and McIntosh, N. (eds.) Forfar and Arneil's Textbook of Pediatrics. Churchill Livingstone: Edinburgh. ISBN 9780443103971
Gibson, B. E.S. and Halsey, C. (2006) Nonimmune neonatal anemias. In: Arceci, R., Hann, I. M. and Smith, O. P. (eds.) Pediatric Hematology. Blackwell Publishing: Malden, pp. 130-150. ISBN 9781405134002 (doi: 10.1002/9780470987001.ch7)
Halsey, C. and Roberts, I. (2003) haemopoietic stem cell transplantation for thalassaemia and sickle cell disease. In: Okpala, I.E. (ed.) Comprehensive Care of Sickle Cell Disease. UNSPECIFIED.
Halsey, C. and Roberts, I. (2003) Neonatal Haematology. In: Forfar, J.O., Arneil, G.C., McIntosh, N., Helms, P. and Smyth, R.L. (eds.) Forfar and Arneil's Textbook of Pediatrics. Churchill Livingstone: Edinburgh. ISBN 9780443071980
Edited Books
Thomas, A.E. and Halsey, C. (2014) Controversies in Pediatric and Adolescent Hematology. Series: Pediatric and Adolescent Medicine. Karger. ISBN 9783318024227
Research Reports or Papers
Welisch, G. et al. (2021) First in Human: who and what makes a cancer phase 1 trial and why are they so important? Project Report. OSF. (doi: 10.17605/OSF.IO/KWHQF).
Conference or Workshop Item
Cousins, A. F., Olivares, O., Michie, A. M. , Gottlieb, E. and Halsey, C. (2017) Association of CNS Involvement in Childhood Acute Lymphoblastic Leukaemia with Cholesterol Biosynthesis Upregulation. Spring Meeting for Clinician Scientists in Training 2017, London, UK, 23 Feb 2017. S35. (doi: 10.1016/S0140-6736(17)30431-2)
Yasar, M. Y. et al. (2013) 3866 An Analysis of Mechanisms of Central Nervous System Infiltration in Acute Lymphoblastic Leukaemia Using Primary Cells Xenografted Into Immunodeficient Mice. 55th ASH Annual Meeting and Exposition, New Orleans, LA, USA, 7-10 Dec 2013.
Conference Proceedings
Williams, M.T., Graham, G. , Gibson, B. and Halsey, C. (2011) Homing to the central nervous system is associated with differential expression of selectins, integrins and chemokine receptors in pre-B acute lymphoblastic leukaemia cell lines. In: 51st Annual Scientific Meeting of the British Society for Haematology, Brighton, UK, 4-6 April 2011, pp. 1-88. (doi: 10.1111/j.1365-2141.2011.08609.x)
Williams, M.T., Graham, G. , Gibson, B. and Halsey, C. (2011) An investigation into the role of interleukin-15 on the growth and survival of pre-B acute lymphoblastic leukaemia cell lines. In: 51st Annual Scientific Meeting of the British Society for Haematology, Brighton, UK, 4-6 April 2011, pp. 1-88. (doi: 10.1111/j.1365-2141.2011.08609.x)
Grants
Grants and Awards listed are those received whilst working with the University of Glasgow.
- ALLTogether BRAIN sub-study PM
Children's Cancer and Leukaemia Group
2025 - 2027
- Translating Cutting-Edge Discovery Science into Patient Benefit
Medical Research Council
2023 - 2030
- Isolating a CML-like patient group in Ph+ ALL - does this alter management?
Children's Cancer and Leukaemia Group
2023 - 2026
- ECMC QQR 2023-2028
Cancer Research UK
2023 - 2024
- Translating the CML-like Ph+ALL population into clinical practice
Beatson Cancer Charity
2023 - 2026
- Targeting metabolic reprogramming to develop novel strategies for CNS-directed therapy in acute lymphoblastic leukaemia
Cancer Research UK
2022 - 2028
- Neurotoxicity Genotyping Project
NHS Greater Glasgow and Clyde
2021 - 2022
- Repurposing gliflozins for T-cell acute lymphoblastic leukaemia therapy
Children's Cancer and Leukaemia Group
2021 - 2024
- Using state of the art lipidomic approaches to understand how acute lymphoblastic leukaemia cells adapt to the central nervous system niche
Wellcome Trust
2021 - 2022
- Identifying drivers of central nervous system involvement in T-cell acute lymphoblastic leukaemia
Children's Cancer and Leukaemia Group
2021 - 2023
- Identifying drivers of central nervous system involvement in T-cell acute lymphoblastic leukaemia
Children's Cancer and Leukaemia Group
2021 - 2024
- ALLTogether1 CSF-FLOW sub-study
Children's Cancer and Leukaemia Group
2021 - 2024
- ALLTogether1 CSF-FLOW sub-study
Children's Cancer and Leukaemia Group
2021 - 2025
- DEVELOPING LEUKAEMIC BIOMARKERS TO ENABLE PERSONALISED CNSDIRECTED THERAPY
Yorkhill Leukaemia & Cancer Research Fund
2020 - 2021
- Supporting Neurodiversity in the Workplace
Wellcome Trust
2020 - 2022
- 14-170 Biomarkers and discovery of new therapeutic targets for chemotherapy associated neurotoxicity
Children with Cancer UK
2019 - 2023
- Unravelling clinical heterogeneity in Philadelphia positive ALL
Children's Cancer and Leukaemia Group
2019 - 2022
- Unravelling clinical heterogeneity in Philadelphia positive ALL
Children's Cancer and Leukaemia Group
2019 - 2022
- ECMC supplement
Chief Scientist Office
2019 - 2020
- Reversal of Glucocorticoid resistance in high risk T-ALL
Action Medical Research
2018 - 2022
- Developing Leukaemic Biomarkers to Enable Personalised CNS-directed Therapy
UK Children's Cancer Study Group
2017 - 2020
- Defining the tumour microenvironment in extramedullary acute leukaemia
Children's Cancer and Leukaemia Group
2017 - 2018
- Glasgow ECMC
Cancer Research UK
2017 - 2019
- Glasgow ECMC
Chief Scientist Office
2017 - 2018
- Deciphering Neurotoxicity During All Therapy Using A Deep Phenotyping-Genotyping Approach
Glasgow Children`s Hospital Charity
2017 - 2020
- Biomarkers and discovery of new therapeutic targets for chemotherapy associated neurotoxicity
Children with Cancer UK
2015 - 2018
- Identifying Novel Targets for eradication of acute lymphoblastic leukaemia in the central nervous system
Chief Scientist Office
2015 - 2017
- Developing single-cell tracking techniques in order to understand how leukaemic cells infiltrate the brain in childhood acute lymphoblastic leukaemia
Tenovus Scotland
2014 - 2016
- Development of a humanised murine model of central nervous system leukaemia
Glasgow Children`s Hospital Charity
2013 - 2015
- An Investigation of Immune Function in Children with Symptomatic Vitamin D Deficiency.
Tenovus Scotland
2012 - 2014
- An investigation of the molecular basis for acute lymphoblastic leukaemia cell migration to the central nervous system
Glasgow Children`s Hospital Charity
2011 - 2013
- An investigation into the molecular basis for B lineage acute lymphoblastic leukaemia migration to extramedullary sites.rn
The Kay Kendall Leukaemia Fund
2010 - 2013
- A Molecular Characterisation of Central Nervous System Leukaemia
Chief Scientist Office
2010 - 2011
- Scottish Senior Clinical Fellowship Scheme
Scottish Funding Council
2010 - 2014
- Understanding the Causes of Central Nervous System Leukaemia
British Society for Haematology
2009 - 2010
Supervision
- Di Fazio, Ilaria
Identifying Clinically Relevant Metabolite and Lipid Markers for Precise Diagnosis and Treatment of CNS-Leukaemia
Research datasets
2022
ROSS, K. , Keith, N. , Abbott, L., Adams, C., Aitken, E., Aslett, O., Basra, S., Bell, I., Bradley, J., Brown, T., Brown, W., Chen, R., Cheskin, L., Corrie, R., de Vries, E., Defty, E., Drake, H., Dunlop, H., Emadi, A. , Evans, J. , Everett, S., Feng, Z., Fraser, A., Gallacher, K. , Gaynor-Kirk, E., Halsey, C. , Harris, F., Hu, J., Hush, G., Jamieson, N. , Jameison, V., Jones, R. , Just, L., Lembo, T. , Lloyd, B., Ma, C.-L., Macdonald, S. , Mathias, M. , McAra, M., McCaffrey, B., Mccluskey, L.-A., Mchattie, L.-S., Mcneill, E., Milliken, A., Mogford, D., Morris, G., Nicoll, M., O'Brien, T., Onwuka, T., Papanastasatou, M., Perry, M. , Prosser, Z., Proudfoot, B., Raman Komnedath, S., Robinson, J. , Sleight, R., Smith, P., Stricevic, M., Tharp, B., Thoresson, V., Thorne, J., Vansteenhouse, H., Welisch, G. and Wu, O. (2022) Symbiotic Futures: Health, Well-being and Care in the Post-Covid World. [Data Collection]
2021
Ross, K., Keith, N. , Jones, R. , Hanna, C. , Afzal, I., Basra, S., Bell, I., Bennie, M., Berger, A., Bilsland, A., Blyth, K. , Borris, A., Boruc, M., Bradley, J., Caryl, J., Cerniauskaite, U., Cheskin, L., Chiwanda, J., Cooper, J. , Debiasse, K., Fegan, S., Ferguson, C., Halsey, C. , Harris, F., Herceg, Z., Hogg, C., Hush, G., Julien, A., Kameda, R., Keith, A., Kelly, J., Konieczna, Z., Lu, M. Y., Mackay, S., Marinescu-Duca, M., Maxwell, M., McCaffrey, R., McGuire, N., McIntyre, D., Moffat-Kyle, T., Mukherjee, L., O'Friel, A., Perry, M. , Prentice, J., Prosser, Z., Proudfoot, B., Raman, S., Robinson, J. , Smith, A., Stewart, S., Stricevic, M., Teal, G., Thomson, H., Wang, Z., Welisch, G., Wu, O. , Wu, H., Young, E. and Young, S. (2021) The Future of Cancer and Collective Intelligence in the Post-Covid World. [Data Collection]